Raynaud's phenomenon triggered by the vasopressin V2 receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome.

Publication:
Raynaud's phenomenon triggered by the vasopressin V2 receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome.

dc.contributor.author	Roca Oporto, F J
dc.contributor.author	Rocha, Jose L
dc.date.accessioned	2023-05-03T13:27:17Z
dc.date.available	2023-05-03T13:27:17Z
dc.date.issued	2021-12-09
dc.identifier.doi	10.1093/ckj/sfab260
dc.identifier.issn	2048-8505
dc.identifier.pmc	PMC8967664
dc.identifier.pmid	35371438
dc.identifier.pubmedURL	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967664/pdf
dc.identifier.unpaywallURL	https://academic.oup.com/ckj/article-pdf/15/4/827/43057982/sfab260.pdf
dc.identifier.uri	http://hdl.handle.net/10668/19739
dc.issue.number	4
dc.journal.title	Clinical kidney journal
dc.journal.titleabbreviation	Clin Kidney J
dc.language.iso	en
dc.organization	Hospital Universitario Virgen del Rocío
dc.page.number	827-828
dc.pubmedtype	Journal Article
dc.rights	Attribution-NonCommercial 4.0 International
dc.rights.accessRights	open access
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/
dc.title	Raynaud's phenomenon triggered by the vasopressin V2 receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome.
dc.type	research article
dc.type.hasVersion	VoR
dc.volume.number	15
dspace.entity.type	Publication